Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Preference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With Etanercept

ClinicalTrials.gov ID: NCT01875991

Public ClinicalTrials.gov record NCT01875991. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 8:25 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-label, Randomized, Crossover Study to Assess the Preference for Autoinjector A Versus Autoinjector B in Rheumatoid Arthritis and Plaque Psoriasis Subjects Treated With Etanercept

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The study will estimate the preference of rheumatoid arthritis (RA) and Plaque Psoriasis (PsO) patients who self inject etanercept for one of two experimental autoinjectors.

Study identification

NCT ID
NCT01875991
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Amgen
Industry
Enrollment
217 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 5, 2013 (Actual)
Primary completion
Mar 4, 2014 (Actual)
Completion
Mar 4, 2014 (Actual)
Last update posted
Sep 4, 2018

2013 – 2014

United States locations

U.S. sites
28
U.S. states
20
U.S. cities
28
Facility City State ZIP Site status
Research Site Huntsville Alabama 35801 —
Research Site Tuscaloosa Alabama 35406 —
Research Site Glendale Arizona 85304 —
Research Site Scottsdale Arizona 85258 —
Research Site Hot Springs Arkansas 71913 —
Research Site San Diego California 92108 —
Research Site San Ramon California 94583 —
Research Site Santa Maria California 93454-6945 —
Research Site Tustin California 92780 —
Research Site Denver Colorado 80230 —
Research Site Dunedin Florida 34698 —
Research Site Tampa Florida 33614 —
Research Site Overland Park Kansas 66215 —
Research Site Louisville Kentucky 40217 —
Research Site Frederick Maryland 21702 —
Research Site Lansing Michigan 48910 —
Research Site Lincoln Nebraska 68516 —
Research Site Orchard Park New York 14127 —
Research Site Bismarck North Dakota 58502 —
Research Site Dayton Ohio 45417 —
Research Site Oklahoma City Oklahoma 73103 —
Research Site Duncansville Pennsylvania 16635 —
Research Site Wyomissing Pennsylvania 19610 —
Research Site Charleston South Carolina 29414 —
Research Site Hixson Tennessee 37343 —
Research Site Austin Texas 78731 —
Research Site Dallas Texas 75231 —
Research Site Clarksburg West Virginia 26301 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 9 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01875991, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 4, 2018 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01875991 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →